Though concerns about pancreatitis and thyroid neoplasms have not been substantiated in large human studies, dermatology-specific safety guidelines remain absent
When discussing weight loss medicines, it is helpful to ask your GP or specialist about: Currently licensed and NICE-approved options available to you on the NHS or privately Eligibility criteria for specific treatments and what monitoring would be required Realistic expectations regarding weight loss outcomes, timescales, and the importance of lifestyle changes alongside medication Potential side effects , including gastrointestinal symptoms commonly associated with GLP-1 receptor agonists, and how these are managed If you experience any suspected side effects from a weight management medicine, you can report these directly to the MHRA via the Yellow Card Scheme (available at yellowcard.mhra.gov.uk)
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
Fillers can help improve the Ozempic face by restoring volume in areas that may look hollow or sunken after weight loss
.png.jpg)
